Science and Political News of 2021
June 2021-Biogen was granted approval for Aducanumab, a drug to reduce amyloid plaques in Alzheimer's patients. We hoped they would go for the "one-two punch" and use Gosuranemab for tau reduction. Unfortunately, they were not seeing a clinical response in Alzheimer's and stopped production. We were devastated! Fortunately, they gave Don medication through June 2023.
At the same time, Congress enacted the William M. Thornberry National Defense Authorization Act. This new law added Parkinsoisms to the list of Agent Orange presumptions. We filed an appeal for Don's case to the VA and waited...due to Covid, the VA was back-logged and nothing happened..